Spyre Therapeutics (SYRE) Q3 2022 Earnings

3NovExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-9.25
-6.25
-3.25
-0.25

Details

Expected EPS
-0.25
Actual EPS
-4.33
Surprise EPS
-4.08
Surprise Percent
+1,632%

Description

Spyre Therapeutics (SYRE) has reported earnings of -4.33 per share for Q3 2022.

0 Comments

Share your thoughts